• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Antibiotic rash in children with mononucleosis much lower than previously reported

bys25qthea
April 16, 2013
in Chronic Disease, Infectious Disease, Pediatrics
Reading Time: 3 mins read
Antibiotic rash in children with mononucleosis much lower than previously reported
Share on FacebookShare on Twitter

Image: PD

1. Antibiotic-induced rash occurred in 33% of study participants with Epstein-Barr virus-associated acute infectious mononucleosis (AIM).

2.  Significantly more children treated with amoxicillin experienced drug-induced rashes than with other antibiotics. 

Evidence Rating Level: 2 (Good) 

Study Rundown:  Initial accounts of antibiotic-induced rash in children with AIM reported a rash incidence ranging from 80%-100%. This study re-evaluated the incidence of antibiotic-induced rash among AIM patients and found a significantly lower incidence of rash. Patients treated with amoxicillin were significantly more likely to experience a drug-induced rash than those treated with other antibiotics. Elevated white blood cell counts, difficulty swallowing, and submandibular lymphadenopathy were more common among patients who did not develop a rash. There was no association between an increased risk for rash development and a past history of atopic disease or previous penicillin exposure. The etiology of antibiotic-associated rash with AIM has yet to be elucidated, and this study does not address underlying pathogenesis of the phenomenon beyond evaluating epidemiologic and clinical markers associated with rash development. Importantly, this study was also conducted at tertiary level facilities, which may introduce a selection bias to more complex disease presentation, and the population evaluated was ethnically homogenous, which may have introduced additional bias.

Click to read the study published today in Pediatrics 

RELATED REPORTS

#VisualAbstract: Low-Dose Amoxicillin is Non-Inferior to High-Dose Amoxicillin in Treating Helicobacter Pylori Infection

Evaluating pediatric sinus antibiotics: effectiveness and safety comparison

Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease

Relevant Reading: Skin rash with infectious mononucleosis and ampicillin

In-Depth [retrospective study]: This study evaluated 238 patients between 0 and 18 years of age at two, tertiary level pediatric medical centers who were diagnosed with AIM by  positive immunoglobulin M viral capsid serology. 173 of these patients were treated with antibiotics. Of these, only 41 patients (32.9%) developed an antibiotic-induced rash, as defined by onset of rash after administration of the antibiotic and up to 48 hours after the final dose. The highest incidence of rash occurred among patients taking amoxicillin (29.5%), which was significantly higher than those treated with amoxicillin and clavulanate (15.5%), cephalosporins (15.4%), macrolides (9%) or penicillin (8.5%). There were no significant differences in demographics between those who did and did not develop a rash.  Patients who did not develop a rash had significantly higher rates of submandibular lymphadenopathy (p = 0.4), dysphagia (p = 0.31), and higher leukocyte counts (p = 0.13).

By Emilia Hermann and Leah H. Carr

More from this author: AAP urges bottle feeding over breastfeeding in mothers with HIV, Pediatric influenza burden remains high despite new vaccination recommendations, Community hospitals rely on greater CT use to diagnose pediatric appendicitis, Cow’s milk consumption linked to increased vitamin D and decreased iron stores in early childhood, Delayed growth seen in children with congenital heart disease, No association found between maternal NSAID use and newborn pulmonary hypertension

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

 

 

 

Tags: amoxicillinampicillinantibiotic-induced rashclavulanateEpstein-Barr viruspenicillinrash
Previous Post

Incidence of pediatric melanoma is increasing

Next Post

Childhood migraine associated with infantile colic

RelatedReports

#VisualAbstract: Low-Dose Amoxicillin is Non-Inferior to High-Dose Amoxicillin in Treating Helicobacter Pylori Infection
StudyGraphics

#VisualAbstract: Low-Dose Amoxicillin is Non-Inferior to High-Dose Amoxicillin in Treating Helicobacter Pylori Infection

January 11, 2025
Patient Basics: Acute Sinusitis
Infectious Disease

Evaluating pediatric sinus antibiotics: effectiveness and safety comparison

November 8, 2023
Resection of colorectal liver metastases may improve cost and longevity
Chronic Disease

Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease

January 30, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Overprescribed and Understocked, A Costly Message, A Bad Wrap and Mauna Loa Erupts Again!

December 14, 2022
Next Post
Childhood migraine associated with infantile colic

Childhood migraine associated with infantile colic

Reducing surgical complications may increase costs

Reducing surgical complications may increase costs

Classics Series, Landmark Trials in Medicine

The STAR*D trials II: Switching antidepressants [Classics Series]

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.